Written question asked by Lord Beamish (Labour) on Thursday, 12 May 2022, in the House of Commons. It was due for an answer on Tuesday, 17 May 2022 (named day). It was answered by Maria Caulfield (Conservative) on Tuesday, 17 May 2022 on behalf of the Department of Health and Social Care.
Botulinum Toxin: Non-surgical Cosmetic Procedures
- Question
-
To ask the Secretary of State for Health and Social Care, what existing regulations are in place to prevent the use of botulax during non-surgical aesthetic procedures.
- Answer
-
The Medicines and Healthcare products Regulatory Agency monitors the safety of all medicines, any emerging new evidence in relation to any illegal use of medicines and will take regulatory action where necessary. Botulax is a brand of botulinum toxin not licensed for use in the United Kingdom. Botulinum toxins are prescription-only medicines and must be prescribed by a registered healthcare professional or medical practitioner. The prescriber may delegate the administration of the medicine to a secondary practitioner who is not required to be a healthcare professional. However, the prescriber retains responsibility for ensuring the treatment is provided safely.
While there have been no specific discussions with the Welsh Government, we are committed to improving the safety of cosmetic procedures. Advice for those considering receiving botulinum toxin injections for cosmetic purposes is available at NHS.UK. This includes ensuring that the chosen practitioner has the skills to perform the procedure safely and recommends asking the practitioner for the name of the product, whether it is licensed and how and where it is made.
Secondary information
- Type
- Written question
- Reference
- 1112
- Session
- 2022-23
- Grouped for answer
- Yes
- Subjects
- Licensing Regulation Botulinum toxin Non-surgical cosmetic procedures HUGEL
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2022-05-21 08:54:30 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/1112
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/1112
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/1112